Suppr超能文献

一氧化氮合酶抑制或柳氮磺胺吡啶对HLA - B27转基因大鼠自发性结肠炎的影响。

Effects of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats.

作者信息

Aiko S, Fuseler J, Grisham M B

机构信息

Department of Molecular and Cellular Physiology, LSU Medical Center, Shreveport, Louisiana 71130-3932, USA.

出版信息

J Pharmacol Exp Ther. 1998 Feb;284(2):722-7.

PMID:9454820
Abstract

The objective of this study was to determine the effects that certain nitric oxide synthase inhibitors have on the spontaneous intestinal and colonic inflammation that develops in HLA-B27 transgenic rats and compare these data to those obtained using sulfasalazine (SZ). In an attempt to more closely mimic the clinical situation, drug treatment was begun after the onset of colitis. HLA-B27 male rats that developed clinical signs of colitis (diarrhea/loose stools) at 17 wk of age were randomized into fours groups consisting of one untreated colitic group and three treatment groups that received either aminoguanidine (AG; 52 micromol/kg/day), NG-nitro-L-arginine methyl ester (L-NAME; 45 micromol/kg/day) or SZ (130 mg/kg/day) in their drinking water for 14 days. Aged-matched Fisher 344 male rats were used as healthy controls. After 3 wk of treatment, ileal and colonic mucosal permeabilities, granulocyte infiltration and nitric oxide were quantified using blood-to-lumen clearance of 51Cr-EDTA, tissue myeloperoxidase activity, and plasma levels of nitrate and nitrite, respectively. We found that both AG and L-NAME but not SZ significantly attenuated the increases in plasma nitrate and nitrite levels. Interestingly, all three drugs were effective at significantly attenuating the increases in myeloperoxidase activity in the distal colon. Treatment with AG and SZ but not L-NAME were effective at significantly attenuating the increase in ileal and colonic permeabilities. Quantitative histological analysis revealed that AG and L-NAME but not SZ significantly attenuated the increase in the mucosal thickness and crypt depth in the distal colon compared to untreated colitis. Taken together, these data demonstrate that oral administration of certain nitric oxide synthase inhibitors or SZ to animals with active colitis attenuates the colonic inflammation by at least two different mechanisms. One mechanism appears to be dependent on inhibition of NO production whereas the other mechanism does not.

摘要

本研究的目的是确定某些一氧化氮合酶抑制剂对HLA - B27转基因大鼠自发性肠道和结肠炎症的影响,并将这些数据与使用柳氮磺胺吡啶(SZ)获得的数据进行比较。为了更紧密地模拟临床情况,在结肠炎发作后开始药物治疗。17周龄出现结肠炎临床症状(腹泻/稀便)的HLA - B27雄性大鼠被随机分为四组,包括一个未治疗的结肠炎组和三个治疗组,后者分别在饮用水中给予氨基胍(AG;52微摩尔/千克/天)、NG - 硝基 - L - 精氨酸甲酯(L - NAME;45微摩尔/千克/天)或SZ(130毫克/千克/天),持续14天。年龄匹配的Fisher 344雄性大鼠用作健康对照。治疗3周后,分别使用51Cr - EDTA的血 - 腔清除率、组织髓过氧化物酶活性以及血浆硝酸盐和亚硝酸盐水平来量化回肠和结肠黏膜通透性、粒细胞浸润和一氧化氮。我们发现AG和L - NAME而非SZ能显著减轻血浆硝酸盐和亚硝酸盐水平的升高。有趣的是,所有三种药物都能有效显著减轻远端结肠髓过氧化物酶活性的升高。AG和SZ而非L - NAME的治疗能有效显著减轻回肠和结肠通透性的增加。定量组织学分析显示,与未治疗的结肠炎相比,AG和L - NAME而非SZ能显著减轻远端结肠黏膜厚度和隐窝深度的增加。综上所述,这些数据表明,给患有活动性结肠炎的动物口服某些一氧化氮合酶抑制剂或SZ可通过至少两种不同机制减轻结肠炎症。一种机制似乎依赖于对一氧化氮产生的抑制,而另一种机制则不依赖于此。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验